Table 3.
Completion rates of follow-ups, details of primary outcome for each host trial, and combined meta-analysis results. Values are percentages (numbers completed/numbers due) unless stated otherwise
| Trial | Sent a card | Not sent a card | Overall | Adjusted odds ratio (95% CI)* | P value |
|---|---|---|---|---|---|
| C-Gall | 87 (96/110) | 86 (93/108) | 87 (189/218) | 1.08 (0.49 to 2.37) | 0.84 |
| CPIT-3 | 90 (142/157) | 90 (139/155) | 90 (281/312) | 1.09 (0.52 to 2.30) | 0.81 |
| DISC | 84 (105/125) | 87 (102/117) | 86 (207/242) | 0.77 (0.37 to 1.58) | 0.47 |
| FUTURE | 95 (147/155) | 96 (133/138) | 96 (280/293) | 0.66 (0.21 to 2.08) | 0.48 |
| ProFHER-2 | 82 (14/17) | 80 (12/15) | 81 (26/32) | 1.05 (0.16 to 6.76) | 0.96 |
| PurE | 65 (13/20) | 70 (19/27) | 68 (32/47) | 0.88 (0.25 to 3.11) | 0.84 |
| REFLECT | 75 (108/144) | 75 (104/138) | 75 (212/282) | 0.97 (0.57 to 1.67) | 0.92 |
| SWHSI-2 | 67 (14/21) | 59 (13/22) | 63 (27/43) | 1.38 (0.40 to 4.79) | 0.61 |
| Overall | 85.3 (639/749) | 85.4 (615/720) | 85.4 (1254/1469) | 0.96 (0.71 to 1.29) | 0.77 |
*
Reference is intervention arm.